Transcription factors as targets for cancer therapy
The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs. That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signalling pathways than there are oncogenic transcription factors. But how could specific transcription-factor activity be inhibited?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3 is a member of a family of seven proteins known to play critical roles in cytokine and growth factor signaling (Darnell, 2002).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Darnell, 2002
Citations
Cites
1 retracted
Aoki, N., & Matsuda, T. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0761 · Cited by 119
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Altered Neural Cell Fates and Medulloblastoma in Mouse patched Mutants
Goodrich, L. V., Milenković, L., Higgins, K. M., & Scott, M. P. (1997) · Science · doi:10.1126/science.277.5329.1109 · Cited by 1,696
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,696
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
The Hedgehog and Wnt signalling pathways in cancer
Taipale, J., & Beachy, P. A. (2001) · Nature · doi:10.1038/35077219 · Cited by 1,393
Signalling downstream of activated mammalian Notch
Jarriault, S., Brou, C., Logeat, F., Schroeter, E. H., Kopan, R., & Israel, A. (1995) · Nature · doi:10.1038/377355a0 · Cited by 1,390
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81925-x · Cited by 1,202
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,158
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90136-1 · Cited by 1,014
Wang, B., Fallon, J. F., & Beachy, P. A. (2000) · Cell · doi:10.1016/s0092-8674(00)80678-9 · Cited by 1,014
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Modularity in development and evolution
Schlosser, G., & Thieffry, D. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<1043::aid-bies11>3.0.co;2-c · Cited by 891
Gene Expression Patterns in Human Liver Cancers
Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., Lai, K.-M., Ji, J., Dudoit, S., Ng, I. O. L., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0023 · Cited by 878
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Signal Transduction and the Control of Gene Expression
Brivanlou, A. H., & Darnell, J. E. (2002) · Science · doi:10.1126/science.1066355 · Cited by 699
The E2F1–3 transcription factors are essential for cellular proliferation
Wu, L., Timmers, C., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P., Wright, F. A., Field, S. J., et al. (2001) · Nature · doi:10.1038/35106593 · Cited by 625
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
Mechanism-Based Target Identification and Drug Discovery in Cancer Research
Gibbs, J. B. (2000) · Science · doi:10.1126/science.287.5460.1969 · Cited by 606
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584
Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., Murone, M., Züllig, S., & Basler, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00679-7 · Cited by 561
Peptide and Protein Recognition by Designed Molecules
Peczuh, M. W., & Hamilton, A. D. (2000) · Chemical Reviews · doi:10.1021/cr9900026 · Cited by 545
Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis
van Dam, H., & Castellazzi, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204239 · Cited by 463
β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
Hovanes, K., Li, T. W. H., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence Marsh, J., Holcombe, R. F., & Waterman, M. L. (2001) · Nature Genetics · doi:10.1038/ng0501-53 · Cited by 458
Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome
Hahn, H., Wojnowski, L., Zimmer, A. M., Hall, J., Miller, G., & Zimmer, A. (1998) · Nature Medicine · doi:10.1038/nm0598-619 · Cited by 452
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442
Fambrough, D., McClure, K., Kazlauskas, A., & Lander, E. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80785-0 · Cited by 439
Transducing Hedgehog: the story so far
Ingham, P. W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3505 · Cited by 436
REIFENBERGER, J., Wolter, M., Weber, R. G., Megahed, M., Ruzicka, T., Lichter, P., & Reifenberger, G. (1998) · PubMed · Cited by 426
Song, H. Y., Rothe, M., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6721 · Cited by 414
Davis, R. L., & Turner, D. L. (2001) · Oncogene · doi:10.1038/sj.onc.1205094 · Cited by 389
Price, M. A., & Kalderon, D. (2002) · Cell · doi:10.1016/s0092-8674(02)00664-5 · Cited by 381
Modulation of STAT signaling by STAT-interacting proteins
Shuai, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203522 · Cited by 379
The Rel/NF-κB family: friend and foe
Perkins, N. D. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01617-0 · Cited by 375
STAT signaling in head and neck cancer
Song, J. I., & Grandis, J. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203483 · Cited by 374
Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells
Malik, S., & Roeder, R. G. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01596-6 · Cited by 370
Wong, C. M., Fan, S. T., & Ng, I. O. L. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1<136::aid-cncr1301>3.0.co;2-r · Cited by 348
Cancer gene therapy: fringe or cutting edge?
McCormick, F. (2001) · Nature Reviews Cancer · doi:10.1038/35101008 · Cited by 346
Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C., Maslyar, D. J., Goldberg, J., Boger, D. L., & Vogt, P. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062036999 · Cited by 326
Eisenman, R. N. (2001) · Genes & Development · doi:10.1101/gad928101 · Cited by 319
p300 Acts as a Transcriptional Coactivator for Mammalian Notch-1
Oswald, F., Täuber, B., Dobner, T., Bourteele, S., Kostezka, U., Adler, G., Liptay, S., & Schmid, R. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7761-7774.2001 · Cited by 318
Regulated nuclear import of the STAT1 transcription factor by direct binding of importin‐α
McBride, K. M., Banninger, G., McDonald, C., & Reich, N. C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1754 · Cited by 289
Vogt, P. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204443 · Cited by 289
A new nuclear component of the Wnt signalling pathway
Thompson, B., Townsley, F., Rosin-Arbesfeld, R., Musisi, H., & Bienz, M. (2002) · Nature Cell Biology · doi:10.1038/ncb786 · Cited by 288
Negative regulation of the JAK/STAT pathway
Starr, R., & Hilton, D. J. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199901)21:1<47::aid-bies6>3.0.co;2-n · Cited by 287
Vogt, P. K., Bos, T. J., & Doolittle, R. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3316 · Cited by 276
Stat1 Depends on Transcriptional Synergy with Sp1
Look, D. C., Pelletier, M. R., Tidwell, R. M., Roswit, W. T., & Holtzman, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30264 · Cited by 268
Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., & Wasik, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.466 · Cited by 262
Catenins, Wnt signaling and cancer
Barker, N., & Clevers, H. C. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<961::aid-bies1>3.0.co;2-t · Cited by 258
Gli proteins and Hedgehog signaling: development and cancer
Ruiz i Altaba, A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01840-5 · Cited by 252
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila
Parker, D. S., Jemison, J., & Cadigan, K. M. (2002) · Development · doi:10.1242/dev.129.11.2565 · Cited by 238
Neoplastic Transformation by Truncated Alleles of Human NOTCH1/TAN1 and NOTCH2
Capobianco, A. J., Zagouras, P., Blaumueller, C. M., Artavanis-Tsakonas, S., & Bishop, J. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6265 · Cited by 230
Antagonists of protein–protein interactions
Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228
Interacting Regions in Stat3 and c-Jun That Participate in Cooperative Transcriptional Activation
Zhang, X., Wrzeszczynska, M. H., Horvath, C. M., & Darnell, J. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7138 · Cited by 225
Kolligs, F. T., Kolligs, B., Hajra, K. M., Hu, G., Tani, M., Cho, K. R., & Fearon, E. R. (2000) · Genes & Development · doi:10.1101/gad.14.11.1319 · Cited by 222
Cheng, S. Y., & Bishop, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082096999 · Cited by 221
A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1
Haspel, R. L., & Darnell, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10188 · Cited by 203
Constitutive activation of nuclear factor ?B in hepatocellular carcinoma
Tai, D.-I., Tsai, S.-L., Chang, Y.-H., Huang, S.-N., Chen, T.-C., Chang, K. S. S., & Liaw, Y.-F. (2000) · Cancer · doi:10.1002/1097-0142(20001201)89:11<2274::aid-cncr16>3.0.co;2-2 · Cited by 201
The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4)
Gallahan, D., & Callahan, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201035 · Cited by 196
Notch signal transduction: a real Rip and more
Weinmaster, G. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00097-6 · Cited by 196
Birner, P., Gatterbauer, B., Oberhuber, G., Schindl, M., Rössler, K., Prodinger, A., Budka, H., & Hainfellner, J. A. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1<165::aid-cncr1305>3.0.co;2-f · Cited by 195
Activation of ternary complex factor Elk-1 by stress-activated protein kinases
Gille, H., Strahl, T., & Shaw, P. E. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00235-1 · Cited by 192
Transducing the Hedgehog Signal
Kalderon, D. (2000) · Cell · doi:10.1016/s0092-8674(00)00129-x · Cited by 190
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells
Kim, D. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.871 · Cited by 160
Ni, H., Ergin, M., Huang, Q., Qin, J., Amin, H. M., Martinez, R. L., Saeed, S., Barton, K., & Alkan, S. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03102.x · Cited by 159
Futreal, P. A., Kasprzyk, A., Birney, E., Mullikin, J. C., Wooster, R., & Stratton, M. R. (2001) · Nature · doi:10.1038/35057046 · Cited by 152
Ras pathway signals are required for notch-mediated oncogenesis
Fitzgerald, K. J., Harrington, A. N., & Leder, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203766 · Cited by 147
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
Penard‐Lacronique, V., Boureux, A., Monni, R., Dumon, S., Mauchauffé, M., Mayeux, P., Gouilleux, F., Berger, R., Gisselbrecht, S., Ghysdael, J., et al. (2000) · Blood · doi:10.1182/blood.v95.6.2076 · Cited by 130
Evolutionary specialization of the nuclear targeting apparatus
Malik, H. S., Eickbush, T. H., & Goldfarb, D. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13738 · Cited by 124
Eymin, B., Gazzéri, S., Brambilla, C., & Brambilla, E. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204242 · Cited by 115
Izban, K. F., Ergin, M., Huang, Q. M., Qin, J., Martinez, R., Schnitzer, B., Ni, H., Nickoloff, B. J., & Alkan, S. (2001) · Modern Pathology · doi:10.1038/modpathol.3880306 · Cited by 102
Aittomäki, S., Pesu, M., Groner, B., Jänne, O. A., Palvimo, J. J., & Silvennoinen, O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5689 · Cited by 100
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson, B., Reich, R., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Berner, A., Ben‐Baruch, G., Bryne, M., & Nesland, J. M. (2001) · PubMed · Cited by 94
Replication-selective viruses for cancer therapy
Biederer, C. H., Ries, S. J., Brandts, C., & McCormick, F. P. (2001) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0295-1 · Cited by 93
Oncogenes and Transcriptional Control
VARMUS, H. E. (1987) · Science · doi:10.1126/science.2825348 · Cited by 75
Molecular diagnosis of lymphoid malignancies by gene expression profiling
Davis, R. E., & Staudt, L. M. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00011 · Cited by 71
Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents
Ohkanda, J., Knowles, D. B., Blaskovich, M. A., Sebti, S. M., & Hamilton, A. D. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394281 · Cited by 70
Park, H. S., Lin, Q., & Hamilton, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082675899 · Cited by 66
Vandel, L., Montreau, N., Vial, E., Pfarr, C. M., Binétruy, B., & Castellazzi, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.1881 · Cited by 56
Denhardt, D. T. (1996) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v7.i3-4.70 · Cited by 55
Tam, W. F., Wang, W., & Sen, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4837-4846.2001 · Cited by 49
Notch signaling as a target in multimodality cancer therapy.
Ms, J., Zlobin, A., Kast, W. M., & Miele, L. (2000) · PubMed · Cited by 43
The diverse role of the ETS family of transcription factors in cancer.
Gilliland, D. G. (2001) · PubMed · Cited by 38
Israë, A. (1997) · Nature · doi:10.1038/41433 · Cited by 35
Signaling Networks and Cell Cycle Control
Gutkind, J. S. (2000) · Humana Press eBooks · doi:10.1385/159259218x · Cited by 35
Abbott, A. (2002) · Nature · doi:10.1038/416470a · Cited by 34
Groner, B., Fritsche, M., Stöcklin, E., Berchtold, S., Merkle, C., Moriggl, R., & Pfitzner, E. (2000) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(00)80004-0 · Cited by 32
A rearranged junD transforms chicken embryo fibroblasts.
Hartl, M., & Vogt, P. K. (1992) · PubMed · Cited by 12
Bachur, N. R. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00006-x · Cited by 8
Hormones and cancer: new insights, new challenges
Tilley, W. D., Clarke, C. L., Birrell, S. N., & Bruchovsky, N. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00393-9 · Cited by 5
The Wnt Signal Transduction Pathway
Barish, G. D., & Williams, B. O. (2003) · Humana Press eBooks · doi:10.1385/1-59259-218-x:53 · Cited by 2
Cited by
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
“Your story matters.”
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
“For example, a number of oncogenic signalling pathways all seem to converge on a limited set of nuclear transcription factor”
BackgroundRevisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Metadata
- Authors
- Darnell, J. E.
- Venue
- Nature Reviews Cancer
- Published
- 2002-10
- Volume
- 2
- Issue
- 10
- Pages
- 740-749
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1980480652
- Cited by
- 1,194
- References
- 109
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 48 · 2022: 37 · 2021: 45 · 2020: 48 · 2019: 48 · 2018: 47 · 2017: 64 · 2016: 50 · 2015: 77 · 2014: 76 · 2013: 87 · 2012: 73
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- transcription factors, cancer therapy, anticancer drug targets, oncogenes, oncogenic transcription factor, signaling pathways, transcription factor inhibition
- MeSH terms
- Antineoplastic Agents, Cytoplasm, Cytoskeletal Proteins, Humans, Ligands, Models, Biological, Mutation, Neoplasms, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Transcription, Genetic, Signal Transduction, Trans-Activators, NF-kappa B, Apoptosis, Zebrafish Proteins, Wnt Proteins, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.